Skip to main content

Advertisement

Open Peer Review Reports for: Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Apr 2018 Submitted Original manuscript
17 Jul 2018 Reviewed Reviewer Report - Giuseppe Palmieri
19 Jul 2018 Reviewed Reviewer Report - Pierosandro Tagliaferri
28 Jul 2018 Reviewed Reviewer Report - Paola Queirolo
16 Aug 2018 Author responded Author comments - Gustavo Fernandes
Resubmission - Version 2
16 Aug 2018 Submitted Manuscript version 2
22 Aug 2018 Reviewed Reviewer Report - Pierosandro Tagliaferri
2 Sep 2018 Reviewed Reviewer Report - Giuseppe Palmieri
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
5 Sep 2018 Editorially accepted
12 Sep 2018 Article published 10.1186/s12885-018-4802-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement